Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Horizon Tumbles — Taking Seagen, Prometheus With It — On Reports FTC Could Block Its Amgen Takeover
09:03am, Tuesday, 16'th May 2023
Reports the FTC could block Amgen's takeover of Horizon reverberated across biotech stocks on Tuesday, with HZNP stock's crash leading the way. The post Horizon Tumbles — Taking Seagen, Prometheus W
Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
07:54am, Tuesday, 16'th May 2023
The deal is bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.
Horizon Therapeutics Stock Plunges on Reports FTC Will Sue to Block Amgen Deal
07:04am, Tuesday, 16'th May 2023
Amgen reached an agreement to buy Horizon for $27.8 billion in December last year, and at the time said it expected the deal to be completed in the first half of 2023.
Dividend Champion, Contender, And Challenger Highlights: Week Of May 14
11:33pm, Saturday, 13'th May 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Amgen Inc. (AMGN) Presents at BofA Securities 2023 Health Care Conference (Transcript)
07:00pm, Saturday, 13'th May 2023
Amgen Inc. (NASDAQ:AMGN ) BofA Securities 2023 Health Care Conference May 9, 2023 11:00 AM ET Company Participants Peter Griffith - CFO Dave Reese - EVP, R&D Conference Call Participants Dan Lundquist
May Dogs Of The Dow: Buy 2, Watch 4
07:12pm, Wednesday, 10'th May 2023
"The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration.” -
TScan Therapeutics stock soars after Amgen collaboration on Crohn's disease treatment that could bring in more than $500 million
09:15am, Tuesday, 09'th May 2023
Shares of TScan Therapeutics Inc. TCRX powered up 43.1% in premarket trading Tuesday, after the biopharmaceutical company announced a collaboration with Amgen Inc. AMGN to treat Crohn's disease that c
16 Stocks Run Circles Around Warren Buffett Over The Long Haul
08:00am, Tuesday, 09'th May 2023
Warren Buffett held court again at Berkshire Hathaway's shareholder meeting. But his company could learn from some other S&P 500 companies.
2 Best Biotech Stocks to Buy Right Now
07:55am, Saturday, 06'th May 2023
Eli Lilly and Amgen both boast exceptional product portfolios and pipelines. The two companies pay growing dividends to shareholders.
2 Magnificent Dividend Stocks to Buy Before the Next Recession
09:45am, Friday, 05'th May 2023
Both of these drugmakers have rich pipelines that will allow them to recover from recent sales slumps. They also offer above-average dividend yields and have raised their payouts regularly over the la
7 Blue-Chip Stocks to Buy in May 2023
06:01pm, Thursday, 04'th May 2023
While large-capitalization enterprises don't offer much excitement, current circumstances may call for the best blue-chip stocks to buy. Frankly, it's getting a little bit toasty on Wall Street, which
Why Amgen Stock Was Sickly Today
06:27pm, Wednesday, 03'rd May 2023
For the most part, the drop wasn't the pharmaceutical's fault. It was mainly due to the underperformance of a potential acquisition.
2 Incredibly Cheap Dividend Stocks to Buy in May
09:45am, Tuesday, 02'nd May 2023
Top-shelf dividend stocks have a strong track record of outperforming the broader markets during an economic recession. Amgen and Johnson & Johnson are two elite dividend-paying pharma stocks that tra
Weight loss drug market is just beginning to take off, says Mizuho's Jared Holz
02:33pm, Friday, 28'th Apr 2023
Jared Holz, Mizuho healthcare equity strategist, joins 'The Exchange' to discuss new weight loss drugs coming to market, forecasts for market expansion in weight loss drugs, and key players in the wei
Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised
12:56pm, Friday, 28'th Apr 2023
Amgen (AMGN) beats estimates for earnings but misses the same for sales. It raises its earnings and sales guidance for 2023.
